| Jul 5 |
Dupixent “addresses current gap” in COPD biologics landscape
|
| Jul 4 |
Upcoming Stock Spinoffs: Should You Pounce or Pass?
|
| Jul 4 |
French State Investment Firm Eyes Stake in Sanofi Consumer Unit
|
| Jul 3 |
Update: Market Chatter: Bain, Cinven Said to Weigh Joint Bid for Sanofi's Consumer Health Division
|
| Jul 3 |
Bain, Cinven Weighing Joint Bid for $20 Billion Sanofi Unit
|
| Jul 3 |
7 Safe Haven Stocks to Buy Before the Next Market Correction
|
| Jul 3 |
Europe Approves Sanofi/Regeneron's Dupixent for 'Smoker's Lungs' A Month After US FDA Asks For Data
|
| Jul 3 |
Regeneron (REGN), SNY Win EC Approval for Dupixent for COPD
|
| Jul 3 |
Novavax’s Second Act: How a Fallen COVID Star Could Rise from the Ashes
|
| Jul 3 |
Sanofi, Regeneron win EU label expansion for Dupixent in COPD
|
